Category: Press

Bloomberg Daybreak Asia: Tony Scherrer on Stock Market Changes

Bloomberg Daybreak Asia: Smead Capital’s Scherrer Sees Mixed Stock Market Changes Coming Hosted by Ramy Inocencio For more information go to www.bloomberg.com. The information contained in this interview represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is

⟶ Keep Reading

CNBC Asia Squawk Box: Bill Smead on US Market Volatility

The market sell-off is only ‘shocking’ because investors got used to smooth sailing Hosted by Bernie Lo & Martin Soong For more information go to www.cnbc.com. Article by Saheli Roy Choudhury. The information contained in this tv appearance represents SCM’s opinions, and should not be

⟶ Keep Reading

Bloomberg Businessweek: Bill Smead discusses American Express

AmEx’s Biggest Problem May Be All Those Executives It Let Leave By Jennifer Surane Stocks mentioned: AMEX For more information go to www.businessweek.com. The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance

⟶ Keep Reading

WSJ: Bill Smead on Wells Fargo

Fed Rebuke Costs Wells Fargo About $29 Billion in Lost Market Value By Emily Glazer For more information go to www.wsj.com. Stocks mentioned: WFC The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past

⟶ Keep Reading

Bloomberg Markets: Bill Smead on the Housing Market

This Rare Bear Who Called the Crash Warns Housing Is Too Hot Again By Prashant Gopal Stocks mentioned: LEN, NVR For more information go to www.bloomberg.com. The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment

⟶ Keep Reading

Financial Times: Bill Smead on Big Banks

Five things to look out for in US bank earnings By Ben McLannahan For more information go to www.ft.com. The information contained in this article represents Smead Capital Management’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no

⟶ Keep Reading

Reuters: Tony Scherrer discusses Merck & Co.

Merck raises stakes in lung cancer as rivals close in By Brendan McDermid   For more information go to www.reuters.com. Stocks mentioned: MRK The information contained in this article represents Smead Capital Management’s opinions, and should not be construed as personalized or individualized investment advice.

⟶ Keep Reading

Barron’s: Tony Scherrer on Target

Target’s Renovation Could Pay Off Nicely for Investors By Vito J. Racanelli For more information go to www.barrons.com. Stocks mentioned: TGT The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no

⟶ Keep Reading
Scroll to Top